ACS Pharmacology & Translational Science is planning to publish a Special Issue titled “Emerging Leaders in Pharmacology & Translational Science” in February 2020, headed up by Dr. Karen Gregory, ARC Future Fellow and Lab Head, Monash Institute of Pharmaceutical Sciences, and Professor Rebecca H. Ritchie, NHMRC Senior Research Fellow and Lab Head, Baker Heart and […]
ACS Pharmacology & Translational Science is planning to publish a Special Issue titled “Emerging Leaders in Pharmacology & Translational Science” in February 2020, headed up by Dr. Karen Gregory, ARC Future Fellow and Lab Head, Monash Institute of Pharmaceutical Sciences, and Professor Rebecca H. Ritchie, NHMRC Senior Research Fellow and Lab Head, Baker Heart and Diabetes Institute. Together they invite graduate students and early career researchers (ECRs) to submit a manuscript by November 1, 2019.
“By providing ECRs what may be their first opportunity to be a corresponding author, we anticipate providing greater exposure of the work they drive and an opportunity to further add to their CV for career development purposes,” Dr. Gregory says.
What to Submit—Deadline: November 1, 2019
“We’re looking for research led by graduate students and early career researchers up to 10-years post-Ph.D. to submit their manuscripts for possible inclusion this Special Issue,” Professor Ritchie says.
Areas of particular interest include:
- Research that challenges existing paradigms for drug action revealing new insights into mechanisms of action from the structural/molecular level through to preclinical models
- New approaches/molecules for well-established drug targets
- Elucidation of novel drug targets or physiological roles
Articles, Letters, Reviews, Perspectives, and Viewpoints are all welcome. For details on requirements for each manuscript type, please consult the Author Guidelines. You can also find the entire ACS Pharmacology & Translational Science scope below.
Learn more about why you should publish your research with ACS Pharmacology & Translational Science.
The journal’s editors give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest, but they will consider all innovative research with articulated translational relevance.
If you’re not sure if your research is within scope, please email the journal’s editorial team at eic@ptsci.acs.org for feedback.
